CA Stock MarketDetailed Quotes

METX ME Therapeutics Holding Inc

Watchlist
  • 8.000
  • 0.0000.00%
15min DelayMarket Closed Feb 5 13:09 ET
209.52MMarket Cap-160.00P/E (TTM)

ME Therapeutics Holding Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
45.24%-145.34K
-117.00%-657.92K
-48.92%-150.26K
2.58%-142.98K
-99.25K
-1,078.96%-265.43K
-123.46%-303.2K
-100.9K
-146.77K
-22.51K
Net income from continuing operations
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
---143.49K
-431.40%-343.11K
-4,372.64%-6.52M
---2.95M
---3.49M
---64.57K
Depreciation and amortization
116,822.22%10.52K
-20.41%39
-25.00%9
-16.67%10
--11
--9
-19.67%49
--12
--12
----
Remuneration paid in stock
-26.49%152.6K
17.45%690.89K
-31.20%170.87K
-10.11%305.5K
--6.92K
--207.6K
4,198.90%588.22K
--248.35K
--339.87K
----
Other non cashItems
-36.70%2.79K
-99.85%8.58K
--0
-99.96%1.25K
--2.93K
--4.4K
51,625.44%5.59M
--2.58M
--2.99M
----
Change In working capital
92.63%-9.89K
-247.48%-62.8K
-165.85%-9.1K
129.20%46.25K
--34.38K
-419.42%-134.33K
394.77%42.58K
--13.82K
--20.18K
--42.05K
-Change in receivables
57.54%-10.1K
-160.76%-9.37K
-239.08%-3.52K
-228.20%-5.05K
--22.98K
---23.78K
175.05%15.42K
---1.04K
---1.54K
----
-Change in prepaid assets
-45.72%-59.21K
47.87%-7.87K
-41.89%-21.74K
-81.57%4.55K
--49.95K
---40.63K
-583.97%-15.1K
---15.32K
--24.7K
----
-Change in payables and accrued expense
184.98%59.41K
-207.80%-45.56K
-46.42%16.17K
1,665.61%46.75K
---38.56K
-266.26%-69.92K
408.48%42.26K
--30.18K
---2.99K
--42.05K
Cash from discontinued investing activities
Operating cash flow
45.24%-145.34K
-117.00%-657.92K
-48.92%-150.26K
2.58%-142.98K
---99.25K
-1,078.96%-265.43K
-123.46%-303.2K
---100.9K
---146.77K
---22.51K
Investing cash flow
Cash flow from continuing investing activities
-19.73K
0
0
757.44K
0
Net PPE purchase and sale
---8.83K
----
----
----
----
----
----
----
----
----
Net business purchase and sale
----
--0
--0
----
----
----
--757.44K
--0
----
----
Net other investing changes
---10.89K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---19.73K
--0
--0
----
----
----
--757.44K
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
-5.45K
1,204.91%1.51M
-106.49%-7.5K
450K
-17.48%115.53K
115.53K
0
125K
Net issuance payments of debt
---5.45K
---40K
--0
--0
----
----
--0
--0
--0
----
Net common stock issuance
----
1,246.03%1.56M
--0
----
----
----
--115.53K
----
----
--125K
Proceeds from stock option exercised by employees
----
---7.5K
----
----
----
----
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
---5.45K
1,204.91%1.51M
-106.49%-7.5K
--450K
----
----
-17.48%115.53K
--115.53K
--0
--125K
Net cash flow
Beginning cash position
131.28%1.5M
736.35%647.15K
161.57%1.65M
6,066.33%1.35M
--381.72K
62.64%647.15K
5.91%77.38K
--632.52K
--21.85K
--397.91K
Current changes in cash
35.76%-170.52K
49.11%849.58K
-1,178.77%-157.76K
-49.72%307.02K
--965.75K
-358.99%-265.43K
13,104.36%569.77K
--14.62K
--610.67K
--102.49K
End cash Position
247.43%1.33M
131.28%1.5M
131.28%1.5M
161.57%1.65M
--1.35M
-23.72%381.72K
736.35%647.15K
--647.15K
--632.52K
--500.4K
Free cash from
41.91%-154.18K
-117.00%-657.92K
-48.92%-150.26K
2.58%-142.98K
---99.25K
-1,078.96%-265.43K
-123.46%-303.2K
---100.9K
---146.77K
---22.51K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 45.24%-145.34K-117.00%-657.92K-48.92%-150.26K2.58%-142.98K-99.25K-1,078.96%-265.43K-123.46%-303.2K-100.9K-146.77K-22.51K
Net income from continuing operations 12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K---143.49K-431.40%-343.11K-4,372.64%-6.52M---2.95M---3.49M---64.57K
Depreciation and amortization 116,822.22%10.52K-20.41%39-25.00%9-16.67%10--11--9-19.67%49--12--12----
Remuneration paid in stock -26.49%152.6K17.45%690.89K-31.20%170.87K-10.11%305.5K--6.92K--207.6K4,198.90%588.22K--248.35K--339.87K----
Other non cashItems -36.70%2.79K-99.85%8.58K--0-99.96%1.25K--2.93K--4.4K51,625.44%5.59M--2.58M--2.99M----
Change In working capital 92.63%-9.89K-247.48%-62.8K-165.85%-9.1K129.20%46.25K--34.38K-419.42%-134.33K394.77%42.58K--13.82K--20.18K--42.05K
-Change in receivables 57.54%-10.1K-160.76%-9.37K-239.08%-3.52K-228.20%-5.05K--22.98K---23.78K175.05%15.42K---1.04K---1.54K----
-Change in prepaid assets -45.72%-59.21K47.87%-7.87K-41.89%-21.74K-81.57%4.55K--49.95K---40.63K-583.97%-15.1K---15.32K--24.7K----
-Change in payables and accrued expense 184.98%59.41K-207.80%-45.56K-46.42%16.17K1,665.61%46.75K---38.56K-266.26%-69.92K408.48%42.26K--30.18K---2.99K--42.05K
Cash from discontinued investing activities
Operating cash flow 45.24%-145.34K-117.00%-657.92K-48.92%-150.26K2.58%-142.98K---99.25K-1,078.96%-265.43K-123.46%-303.2K---100.9K---146.77K---22.51K
Investing cash flow
Cash flow from continuing investing activities -19.73K00757.44K0
Net PPE purchase and sale ---8.83K------------------------------------
Net business purchase and sale ------0--0--------------757.44K--0--------
Net other investing changes ---10.89K------------------------------------
Cash from discontinued investing activities
Investing cash flow ---19.73K--0--0--------------757.44K--0--------
Financing cash flow
Cash flow from continuing financing activities -5.45K1,204.91%1.51M-106.49%-7.5K450K-17.48%115.53K115.53K0125K
Net issuance payments of debt ---5.45K---40K--0--0----------0--0--0----
Net common stock issuance ----1,246.03%1.56M--0--------------115.53K----------125K
Proceeds from stock option exercised by employees -------7.5K------------------0------------
Cash from discontinued financing activities
Financing cash flow ---5.45K1,204.91%1.51M-106.49%-7.5K--450K---------17.48%115.53K--115.53K--0--125K
Net cash flow
Beginning cash position 131.28%1.5M736.35%647.15K161.57%1.65M6,066.33%1.35M--381.72K62.64%647.15K5.91%77.38K--632.52K--21.85K--397.91K
Current changes in cash 35.76%-170.52K49.11%849.58K-1,178.77%-157.76K-49.72%307.02K--965.75K-358.99%-265.43K13,104.36%569.77K--14.62K--610.67K--102.49K
End cash Position 247.43%1.33M131.28%1.5M131.28%1.5M161.57%1.65M--1.35M-23.72%381.72K736.35%647.15K--647.15K--632.52K--500.4K
Free cash from 41.91%-154.18K-117.00%-657.92K-48.92%-150.26K2.58%-142.98K---99.25K-1,078.96%-265.43K-123.46%-303.2K---100.9K---146.77K---22.51K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.